Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World Setting

INTRODUCTION: Insulin degludec/liraglutide (IDegLira) is a fixed-ratio combination (FRC) of basal insulin and glucagon-like protein-1 receptor agonist (GLP-1 RA) that has demonstrated glycemic and metabolic benefits in patients with type 2 diabetes mellitus (T2DM) in both randomized controlled trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Melzer-Cohen, Cheli, Chodick, Gabriel, Naftelberg, Shiran, Shehadeh, Naim, Karasik, Avraham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965556/
https://www.ncbi.nlm.nih.gov/pubmed/31808132
http://dx.doi.org/10.1007/s13300-019-00725-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965556/
https://www.ncbi.nlm.nih.gov/pubmed/31808132
http://dx.doi.org/10.1007/s13300-019-00725-9

Ejemplares similares